Your browser doesn't support javascript.
loading
Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis.
Verzijl, Cristy R C; Van De Peppel, Ivo P; Struik, Dicky; Jonker, Johan W.
Affiliation
  • Verzijl CRC; Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Van De Peppel IP; Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Struik D; Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Jonker JW; Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Expert Opin Investig Drugs ; 29(2): 125-133, 2020 Feb.
Article in En | MEDLINE | ID: mdl-31899984

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Fibroblast Growth Factors / Non-alcoholic Fatty Liver Disease Limits: Animals / Humans Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Fibroblast Growth Factors / Non-alcoholic Fatty Liver Disease Limits: Animals / Humans Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: Netherlands